Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andy Kieu

Clinical Cardiac Electrophysiology Milwaukee, WI Doctor of Osteopathy

NPI 1215355730 CMS profile 4227629

2801 W Kinnickinnic River Pkwy, Milwaukee, WI 53215

Open in the dashboard

General payments

$62,085

280 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andy Kieu of Milwaukee, WI is reported in the CMS Open Payments database as having received $62,085 across 280 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,666 74
2024 General $12,249 70
2023 General $8,140 64
2022 General $5,659 41
2021 General $15,002 14
2020 General $10,333 8
2019 General $1,036 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andy Kieu
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Andy Kieu were reported at $9,666. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Andy Kieu Clinical Cardiac Electrophysiology median Middle half National median
2019 $1,036 $2,361 $585–$8,260 $163
2020 $10,333 $993 $247–$4,351 $114
2021 $15,002 $1,185 $326–$4,739 $132
2022 $5,659 $2,073 $554–$6,789 $149
2023 $8,140 $2,568 $759–$8,159 $160
2024 $12,249 $2,557 $703–$7,403 $164
2025 $9,666 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $28,703 155 payments
  2. Abbott Laboratories $13,556 78 payments
  3. Boston Scientific Corporation $8,341 11 payments
  4. Medtronic Vascular, Inc. $6,356 2 payments
  5. Biotronik Inc. $2,445 11 payments
  6. Medical Device Business Services, Inc. $1,142 6 payments
  7. Astellas Pharma US Inc $353 4 payments
  8. Janssen Pharmaceuticals, Inc $345 3 payments
  9. Biosense Webster, Inc. $345 4 payments
  10. Cardiovascular Systems Inc. $141 1 payment
  11. Other $358 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $23,822 7 payments
  2. Travel and Lodging $19,117 85 payments
  3. Food and Beverage $13,406 173 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,500 4 payments
  5. Education $1,241 11 payments
Products named General payments · program years 2019–2025
  1. Micra $8,014 56 payments
  2. EMBLEM S ICD ELECTRODE DELIVERY SYSTEM $7,500 2 payments
  3. ENSITE PRECISION $6,727 46 payments
  4. TactiCath SE $2,250 1 payment
  5. Acticor 7 VR-T DX $1,531 6 payments
  6. Rivacor 7 DR-T $1,482 4 payments
  7. Carto 3 $1,406 9 payments
  8. Edora 8 DR-T $1,377 3 payments
  9. Solia $1,377 3 payments
  10. BioMonitor $1,377 3 payments
  11. Other $8,417 76 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

1,823

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$593,747

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

34.9%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 484 $485,233
Xarelto Rivaroxaban Brand 80 $76,829
Dofetilide Generic 53 $8,571
Metoprolol Succinate Generic 460 $7,772
Flecainide Acetate Generic 143 $6,306
Amiodarone Hcl Generic 208 $4,417
Metoprolol Tartrate Generic 163 $1,041
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 42 $1,018
Carvedilol Generic 49 $561
Dilt-Xr Diltiazem Hcl Brand 12 $462

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 71 billing codes

Paid by Medicare

$166,918

Medicare's payments for the services billed

Medicare patients

2,293

Average age 74

Services billed

5,262

1,103 women, 1,190 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 59%
Arthritis 54%
Heart failure 52%
Atrial fibrillation 52%
Chronic kidney disease 52%
Diabetes 41%
Depression 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

280 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record